Data as of Mar 07
| +1.12 / +0.88%|
The 20 analysts offering 12-month price forecasts for Allergan Inc have a median target of 131.00, with a high estimate of 150.00 and a low estimate of 95.00. The median estimate represents a +2.35% increase from the last price of 127.99.
The current consensus among 24 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.